Rezolute, Inc. (RZLT)
3.13
-0.01
(-0.32%)
USD |
NASDAQ |
May 07, 15:45
Rezolute SG&A Expense (TTM) : 26.27M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| XOMA Royalty Corp. | 36.09M |
| Ligand Pharmaceuticals, Inc. | 92.45M |
| ADMA Biologics, Inc. | 96.42M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |